News - Page 218 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin

Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin

Post published:January 14, 2021
Post category:Press Release

Read more about the article MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience

MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience

Post published:January 14, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Strengthens Board of Directors With Appointment of Gregory M. McKee

Tryp Therapeutics Strengthens Board of Directors With Appointment of Gregory M. McKee

Post published:January 14, 2021
Post category:Press Release

Read more about the article NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials

Post published:January 14, 2021
Post category:Press Release

Read more about the article Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

Post published:January 14, 2021
Post category:Press Release

Read more about the article Red Light Holland Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended September 30, 2020 and Material Change Report

Red Light Holland Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended September 30, 2020 and Material Change Report

Post published:January 14, 2021
Post category:Press Release

Read more about the article Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore

Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore

Post published:January 13, 2021
Post category:Press Release

Read more about the article PharmaTher Approved to Trade on the OTCQB Venture Market

PharmaTher Approved to Trade on the OTCQB Venture Market

Post published:January 13, 2021
Post category:Press Release

Read more about the article Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

Post published:January 13, 2021
Post category:Press Release

Read more about the article Novamind Expands Psychedelic Medicine Access in Utah

Novamind Expands Psychedelic Medicine Access in Utah

Post published:January 13, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.